idexx laboratories inc (IDXX) Snapshot

IDEXX Laboratories, Inc. Presents at William Blair & Company 33(rd) Annual Growth Stock Conference, Jun-11-2013 09:30 AM. Venue: Four Seasons Hotel, Chicago, Illinois, United States. Speakers: Jonathan W. Ayers, Chairman, Chief Executive Officer and President.

IDEXX Laboratories, Inc. announced that in connection with her previously announced retirement from the company effective following the company's Annual Meeting of Stockholders, which was held on May 8, 2013, Merilee Raines resigned as Chief Financial Officer of the company and ceased serving as the Company's principal financial officer and principal accounting officer, effective as of May 10, 2013. Effective May 10, 2013, the company appointed, on an interim basis, Willard R. Blanche Jr., the company's Vice President of Finance, as acting Chief Financial Officer of the company and Jeffery D. Chadbourne, Director of Corporate Accounting and Financial Reporting, as acting Principal Accounting Officer of the company. Biographical information for Mr. Blanche and Mr. Chadbourne. Willard R. Blanche Jr. Mr. Blanche, age 39, has served as the company's Vice President of Finance since January 2013. Prior to that, Mr. Blanche held a series of roles within the company's finance organization, including Senior Director of Finance from July 2012 to January 2013 and Director of Finance for the company's reference laboratories line of business from November 2011 to July 2012. Jeffery D. Chadbourne. Mr. Chadbourne, has served as the company's Director of Corporate Accounting and Financial Reporting since September 2011. Mr. Chadbourne came to IDEXX from Pierce Promotions and Event Management LLC. He then served as Senior Vice President of Finance from 2006 to 2010, and from June 2011, was Chief Financial Officer.

IDEXX Laboratories, Inc. announced the successful refinancing of its unsecured revolving credit facility. As part of the refinancing, which closed on May 9, 2013, the company entered into an amended and restated credit agreement that increased the aggregate commitments available for borrowing from $300.0 million to $450.0 million and extended the maturity date from July 25, 2016 to May 8, 2018. The interest rates applicable to borrowings under the credit facility as well as the sole financial covenant remain unchanged. The revolving credit facility continues to be available for general corporate purposes.